Business Segments · D&A
Orthopaedics — D&A
Stryker Orthopaedics — D&A increased by 8.2% to $119M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.2%, from $107M to $119M. Over 3 years (FY 2022 to FY 2025), Orthopaedics — D&A shows an upward trend with a 7.3% CAGR.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2022
Last reportedQ1 2026May 11, 2026
Rolls up toD&A
How to read this metric
An increase often reflects significant recent capital investment or the amortization of acquired technology assets.
Detailed definition
This represents the non-cash allocation of the cost of tangible and intangible assets used by the Orthopaedics segment o...
Peer comparison
Commonly reported as part of segment-level operating performance in capital-intensive healthcare sectors.
Metric ID:
syk_segment_orthopaedics_depreciation_and_amortizationHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $87.5M | $87.5M | $87.5M | $87.5M | $96.5M | $96.5M | $96.5M | $96.5M | $108M | $105M | $112M | $108M | $107M | $104M | $111M | $110M | $119M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +10.3% | +0.0% | +0.0% | +0.0% | +11.9% | -2.8% | +6.7% | -3.6% | -0.9% | -2.8% | +6.7% | -0.9% | +8.2% |
| YoY Change | — | — | — | — | +10.3% | +10.3% | +10.3% | +10.3% | +11.9% | +8.8% | +16.1% | +11.9% | -0.9% | -1.0% | -0.9% | +1.9% | +11.2% |
Range$87.5M – $119M
CAGR+8.0%
Avg YoY Growth+7.7%
Median YoY Growth+10.3%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Stryker's orthopaedics — d&a?
- Stryker (SYK) reported orthopaedics — d&a of $119M in Q1 2026.
- How has Stryker's orthopaedics — d&a changed year-over-year?
- Stryker's orthopaedics — d&a increased by 11.2% year-over-year, from $107M to $119M.
- What is the long-term trend for Stryker's orthopaedics — d&a?
- Over 3 years (2022 to 2025), Stryker's orthopaedics — d&a has grown at a 7.3% compound annual growth rate (CAGR), from $350M to $432M.
- What does orthopaedics — d&a mean?
- The non-cash expense representing the aging of assets used in the orthopedic business.